July 14, 2016 — BBMK Technologies recently announced the launch of ClotMD, a cloud-based application and mobile solution. The software-as-a-service (SaaS)-based solution allows healthcare providers to overcome the challenges of managing patients on anticoagulant medication, specifically warfarin.
Healthcare providers can easily manage on-site testing or home INR monitoring while enhancing patient medication adherence and improving their business. With ClotMD, providers have access to a fully integrated warfarin monitoring solution, allowing patients to engage actively in their health for an improved outcome on any computer or mobile device.
Patients who are on warfarin to manage anticoagulation require consistent and ongoing testing of INR levels to maintain within therapeutic range and avoid potentially serious health implications. ClotMD is designed to help healthcare providers manage their warfarin patient population while improving day-to-day business processes. Providers can now focus on patients who require their attention when they fall outside of target therapeutic range or are non-compliant with prescribed medication and/or testing.
The app works on any computer or mobile device, providing a real-time connection between providers and patients. ClotMD allows for convenient management of INR levels, dosing calculations and testing schedules.
The ClotMD mobile app makes patient-centric care possible by delivering real-time alerts on INR levels, scheduled testing and medication reminders. Further, patients can also receive automatic notifications from their healthcare provider alerting them to a warfarin dosage change. A built-in diet library offers another layer of support for patients who want to be proactive regarding their health. History of current and previous INR levels can be tracked and shared by the patient.
For more information: www.clotmd.com